We narrowed to 1,318 results for: SCFV
-
Plasmid#220406PurposeMammalian Expression Plasmid of anti-PSD-93/Chapsyn-110 (Rat) IgG2a R-mAb. Derived from hybridoma N18/2.DepositorInsertAnti-PSD-93/Chapsyn-110 (Rattus novegicus) recombinant mouse monoclonal antibody. (Dlg2 Mouse)
ExpressionMammalianPromoterDual CMVAvailable SinceSept. 5, 2024AvailabilityAcademic Institutions and Nonprofits only -
Anti-LRRK2/Dardarin kinase, C-terminus [N241A/58R]
Plasmid#220411PurposeMammalian Expression Plasmid of anti-LRRK2/Dardarin kinase, C-terminus (Human) IgG2a R-mAb. Derived from hybridoma N241A/58DepositorInsertAnti-LRRK2/Dardarin kinase, C-terminus (Homo sapiens) recombinant mouse monoclonal antibody. (LRRK2 Mouse)
ExpressionMammalianPromoterDual CMVAvailable SinceSept. 5, 2024AvailabilityAcademic Institutions and Nonprofits only -
Anti-Beta-2 adrenergic receptor [N430/30R]
Plasmid#220412PurposeMammalian Expression Plasmid of anti-Beta_2 adrenergic receptor (Mouse) IgG2a R-mAb. Derived from hybridoma N430/30DepositorInsertAnti-Beta-2 adrenergic receptor (Mus musculus) recombinant mouse monoclonal antibody. (Adrb2 Mouse)
ExpressionMammalianPromoterDual CMVAvailable SinceSept. 5, 2024AvailabilityAcademic Institutions and Nonprofits only -
Anti-Cavalpha2delta2 Ca2+ channel [N492/39R]
Plasmid#220415PurposeMammalian Expression Plasmid of anti-Cavalpha2delta2 Ca2+ channel (Mouse) IgG2a R-mAb. Derived from hybridoma N492/39DepositorInsertAnti-Cavalpha2delta2 Ca2+ channel (Mus musculus) recombinant mouse monoclonal antibody. (Cacna2d2 Mouse)
ExpressionMammalianPromoterDual CMVAvailable SinceSept. 5, 2024AvailabilityAcademic Institutions and Nonprofits only -
Anti-Cavalpha2delta2 Ca2+ channel [N492/93R]
Plasmid#220416PurposeMammalian Expression Plasmid of anti-Cavalpha2delta2 Ca2+ channel (Mouse) IgG2a R-mAb. Derived from hybridoma N492/93DepositorInsertAnti-Cavalpha2delta2 Ca2+ channel (Mus musculus) recombinant mouse monoclonal antibody. (Cacna2d2 Mouse)
ExpressionMammalianPromoterDual CMVAvailable SinceSept. 5, 2024AvailabilityAcademic Institutions and Nonprofits only -
Anti-SK2 K+ channel [K78/29R-2b]
Plasmid#220421PurposeMammalian Expression Plasmid of anti-SK2 K+ channel (Rat) subclass-switched IgG2b R-mAb. Derived from hybridoma K78/29.DepositorInsertAnti-SK2 K+ channel (Rattus norvegicus) recombinant mouse monoclonal antibody. (Kcnn2 Mouse)
ExpressionMammalianPromoterDual CMVAvailable SinceSept. 5, 2024AvailabilityAcademic Institutions and Nonprofits only -
Anti-Kir2.3 K+ channel [N25/35R-2b]
Plasmid#220427PurposeMammalian Expression Plasmid of anti-Kir2.3 K+ channel (Human) subclass-switched IgG2b R-mAb. Derived from hybridoma N25/35.DepositorInsertAnti-Kir2.3 K+ channel (Homo sapiens) recombinant mouse monoclonal antibody. (KCNJ4 Mouse)
ExpressionMammalianPromoterDual CMVAvailable SinceSept. 5, 2024AvailabilityAcademic Institutions and Nonprofits only -
Anti-Kv7.1/KCNQ1 K+ channel [N37A/10R-2b]
Plasmid#220431PurposeMammalian Expression Plasmid of anti-Kv7.1/KCNQ1 K+ channel (Human) subclass-switched IgG2b R-mAb. Derived from hybridoma N37A/10.DepositorInsertAnti-Kv7.1/KCNQ1 K+ channel (Homo sapiens) recombinant mouse monoclonal antibody. (KCNQ1 Mouse)
ExpressionMammalianPromoterDual CMVAvailable SinceSept. 5, 2024AvailabilityAcademic Institutions and Nonprofits only -
Anti-Kv1.2 K+ channel [K14/16R-rat IgG2a]
Plasmid#222176PurposeMammalian Expression Plasmid of anti-Kv1.2 K+ channel (Human). Derived from hybridoma K14/16.DepositorInsertAnti-Kv1.2 K+ channel (Homo sapiens) recombinant mouse monoclonal antibody. (KCNA2 Chimera: M. musculus (mouse)/R. norvegicus (rat))
ExpressionMammalianPromoterDual CMVAvailable SinceSept. 5, 2024AvailabilityAcademic Institutions and Nonprofits only -
Anti-CASPR/Neurexin IV [K65/35R-rat IgG2a]
Plasmid#222178PurposeMammalian Expression Plasmid of anti-CASPR/Neurexin IV (Rat). Derived from hybridoma K65/35.DepositorInsertAnti-CASPR/Neurexin IV (Rattus norvegicus) recombinant mouse monoclonal antibody. (Cntnap1 Chimera: M. musculus (mouse)/R. norvegicus (rat))
ExpressionMammalianPromoterDual CMVAvailable SinceSept. 5, 2024AvailabilityAcademic Institutions and Nonprofits only